Converting Amphetamines - An Approximate Tool

Oct 12, 2026

This medical reference tool provides a standardized framework for clinicians to estimate equivalent daily dosages when transitioning patients between various amphetamine-based stimulant medications. It establishes Adderall XR as the primary reference point, offering specific conversion factors for Adzenys, Evekeo, Dexedrine XR, and Vyvanse. Designed as a practical resource for psychiatrists and healthcare professionals, this guide facilitates safer medication management by clarifying the approximate therapeutic ratios between these stimulants. The document emphasizes that while the Adzenys conversion is precise, other calculations remain approximate, requiring careful clinical judgment during patient care. As part of The Carlat Psychiatry Report, this table supports evidence-based prescribing practices, ensuring accuracy when adjusting treatment regimens in clinical psychiatry settings to optimize patient outcomes while managing potential side effects associated with stimulant therapy adjustments.

LanguageEnglish

CategoryGeneral

FormatPDF

Pages1

AccessFree to download

Converting Amphetamines - An Approximate Tool

Medication Conversion Factors

Source Information

FAQs

What is the primary reference medication for these conversions?

Adderall XR serves as the base reference medication for calculating the conversion factors of the other listed stimulants.

Are all conversion factors provided in the tool considered exact?

No, the conversion for Adzenys is exact, while the conversion factors for Evekeo, Dexedrine XR, and Vyvanse are approximate and intended for clinical guidance.

Where was this conversion tool originally published?

It was published in The Carlat Psychiatry Report, Volume 16, Number 11&12, in the November/December 2018 issue.

Oct 12, 2026

Uploaded by Malam Tenang